NGVTNGVTBasic Materials · Specialty Chemicals

NGVT Stock Forecast: Ingevity Corp. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$70
+1.36% on the day

The 3 Wall Street analysts covering Ingevity Corp. hold a median 12-month price target of $90 — +28.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 99 of 100 as at 21 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$2.4B
Ticker Nerd rank
99 / 100
Median analyst target
$90
Analysts covering
3
Total return, dividends reinvested
1W
−8.5%
1M
−6.1%
YTD
+18.7%
1Y
+28.8%
From 52W high
−9.8%
From 52W low
+52.1%
$46
$78
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NGVT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Ingevity Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Aug 2026
99 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Issuance
99
Accruals
98
Revisions
93
Quality
92
Value
90
Momentum
80
Volatility
51
Growth
37
Size
33

Issuance (99): The share count has been shrinking and the company is not leaning on new borrowing.

Growth (37): Sales and profits are flat, shrinking, or growing more slowly than they were.

Size (33): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NGVT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NGVT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$50$60$70$80$90Oct 25Jan 26Apr 26Jul 26NGVTHigh $92Median $90Low $85

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $85Median $90High $92

The green dot is the last close — the median target sits +28.1% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
27 Feb 2026Wells FargoMaintainsEqual-Weight$65$75
29 Jan 2026Wells FargoMaintainsEqual-Weight
19 Dec 2025Wells FargoMaintainsEqual-Weight
10 Dec 2025BMO CapitalMaintainsOutperform
12 Nov 2025Wells FargoMaintainsEqual-Weight
5 Sept 2025BMO CapitalMaintainsOutperform
7 Aug 2025BMO CapitalMaintainsOutperform
14 July 2025Wells FargoMaintainsEqual-Weight
7 May 2025Wells FargoMaintainsEqual-Weight
9 Apr 2025Wells FargoMaintainsEqual-Weight
26 Feb 2025BMO CapitalUpgradeOutperform
20 Feb 2025BMO CapitalMaintainsMarket Perform
31 Oct 2024BMO CapitalMaintainsMarket Perform
30 Sept 2024BMO CapitalMaintainsMarket Perform
5 Aug 2024BMO CapitalMaintainsMarket Perform
5 Aug 2024Wells FargoMaintainsEqual-Weight
1 Aug 2024OppenheimerMaintainsOutperform
11 July 2024Wells FargoMaintainsEqual-Weight
8 May 2024BMO CapitalMaintainsMarket Perform
7 May 2024Loop CapitalMaintainsHold

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NGVT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

NGVT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+9.2%
Analysts raising
2
Analysts cutting
0
Fundamentals

Ingevity Corp. (NGVT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
99.0×

Cheaper than 7% of US stocks

Price / sales
2.1×

Cheaper than 52% of US stocks

Price / book
51.7×

Cheaper than 2% of US stocks

EV / EBITDA
9.5×

Cheaper than 40% of US stocks

Growth & margins
Revenue growth (YoY)
−5.2%

Higher than 20% of US stocks

Earnings growth (YoY)
−14.0%

Higher than 23% of US stocks

Gross margin
44.3%

Higher than 56% of US stocks

Operating margin
29.9%

Higher than 87% of US stocks

Net margin
4.7%

Higher than 59% of US stocks

Returns & dividend
Return on equity
30.1%

Higher than 88% of US stocks

Return on assets
10.4%

Higher than 93% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

NGVT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Chemicals
CompanyMarket capTKN rank
NGVTIngevity Corp.$2.4B
99
HWKNHawkins, Inc.$2.5B
70
CCThe Chemours Co.$2.4B
62
IOSPInnospec, Inc.$2.3B
87
KWRQuaker Houghton$2.8B
92
MTXMinerals Technologies, Inc.$2.2B
70
WDFCWD-40 Co.$2.9B
71

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Ingevity Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NGVT news & analysis

Ingevity included in TIME America's Best Companies 2026 list

Business Wire · 18 Aug 2026positive

Ingevity has been included in TIME's America's Best Companies 2026 list, as announced in a Business Wire release from its North Charleston, South Carolina location.

Why it matters — This national recognition highlights Ingevity as a notable company and may enhance its reputation among investors and stakeholders following the company's operations.

NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes

Zacks Investment Research · 6 Aug 2026positive

Ingevity's Q2 earnings beat estimates, with pricing, mix and higher volumes lifting margins. The company responded by raising its 2026 earnings and EBITDA guidance.

Why it matters — A NGVT watcher would care because the earnings beat and upward revision to 2026 earnings and EBITDA guidance point to improving margin performance.

Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact

Business Wire · 5 Aug 2026positive

Ingevity Corporation published its 2025 Sustainability Report titled "A Decade of Performance, a Future of Possibility," detailing the company's sustainability performance and impact.

Why it matters — The report provides NGVT watchers with a formal update on the company's environmental, social and governance progress, which may influence how investors and stakeholders assess its long-term operational and reputational risk.

Ingevity Q2 Earnings Call Highlights

MarketBeat · 31 July 2026positive

Ingevity reported second-quarter 2026 results with higher adjusted earnings, margin expansion, and progress on portfolio simplification, and raised its full-year adjusted EBITDA and EPS outlook.

Why it matters — A NGVT watcher would care because the company posted improved earnings and margins while raising its full-year financial outlook, signaling stronger expected performance.

Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript

Seeking Alpha · 30 July 2026neutral

Ingevity Corporation held its Q2 2026 earnings call, during which management discussed the company's financial results for the quarter.

Why it matters — An NGVT watcher would care because earnings calls provide direct insight into the company's performance and management's outlook.

FAQ

Frequently asked questions about NGVT stock

What is the NGVT stock price forecast for 2026-2027?

The 3 Wall Street analysts covering Ingevity Corp. have a median 12-month price target of $90, with estimates ranging from $85 to $92. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NGVT stock a buy right now?

Of the 3 analysts covering Ingevity Corp., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Ingevity Corp. 99 out of 100 across roughly 4,600 US stocks as at 21 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NGVT?

As at 21 Aug 2026, Ingevity Corp. ranks 99 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (99 of 100).

Will NGVT stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +28.1% from the last close, and Ticker Nerd's factor model ranks Ingevity Corp. 99 out of 100 as at 21 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NGVT stock forecast for 2030?

No analyst covering Ingevity Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NGVT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $85 to $92 over the next 12 months.

How has NGVT stock performed over the past year?

Ingevity Corp. returned +28.8% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Ingevity Corp. do?

Ingevity Corporation is a leading manufacturer of specialty chemicals and high-performance carbon materials. Its primary function lies in providing innovative solutions aimed at enhancing the performance and sustainability of a wide array of products used in everyday life.

What is the latest news on NGVT?

The most recent item we track (Business Wire, 18 Aug 2026): "Ingevity included in TIME America's Best Companies 2026 list". Ingevity has been included in TIME's America's Best Companies 2026 list, as announced in a Business Wire release from its North Charleston, South Carolina location.

Company

About Ingevity Corp.

Ingevity Corporation is a leading manufacturer of specialty chemicals and high-performance carbon materials. Its primary function lies in providing innovative solutions aimed at enhancing the performance and sustainability of a wide array of products used in everyday life. The company is particularly influential in the automotive industry, where its activated carbon products are crucial in reducing vehicle emissions—a key component in environmental compliance. Additionally, Ingevity's chemical solutions play a significant role in the production of adhesives, lubricants, and pavement technologies. The company’s operations are vital to sectors such as transportation, construction, and industrial applications, highlighting its broad impact across various industries. Ingevity Corporation traces its roots back decades, bringing a rich history of expertise and innovation to its modern initiatives. It underscores its dedication to sustainability not just through product offerings but also by emphasizing responsible manufacturing processes. In the market, Ingevity serves as a pivotal player in the specialty chemicals segment, providing key raw materials and solutions that promote efficiency and environmental responsibility across multiple industries.

CEO Mr. David H. Li · 1,600 employees · United States · https://www.ingevity.com